Point72 Asset Management
CLCD

Point72 Asset Management’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Point72 Asset Management’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-139,900
Closed -$5.09M – 1051
2016
Q4 		$5.09M Buy
139,900
+47,116
+51% +$1.67M 0.04% 449
2016
Q3 		$3.54M Buy
+92,784
New +$1.37M 0.02% 480

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Point72 Asset Management's CLCD Position: Q1 2017 in Review

Point72 Asset Management sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 139,900 shares — an estimated $5.09M sold.

Point72 Asset Management first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $5.09M in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Point72 Asset Management reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Point72 Asset Management sold 139,900 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $5.09M.
  • Point72 Asset Management first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
  • Point72 Asset Management's CoLucid Pharmaceuticals, Inc. position peaked at $5.09M in Q4 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Point72 Asset Management's 13F filing for Q1 2017, filed 15 May 2017.